| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.27 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |